Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The liver X receptors.

Deepak S Lala1

  • 1Pfizer Global Research and Development, Ann Arbor, MI 48105, USA. deepak.s.lala@pfizer.com

Current Opinion in Investigational Drugs (London, England : 2000)
|September 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of sub-chronic selective 11β-hydroxysteroid dehydrogenase 1 inhibition on the hypothalamic-pituitary-adrenal axis in female cynomolgus monkeys.

European journal of pharmacology·2016
Same author

Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists.

Bioorganic & medicinal chemistry·2016
Same author

Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetes.

European journal of pharmacology·2014
Same author

The medicinal chemistry of liver X receptor (LXR) modulators.

Journal of medicinal chemistry·2014
Same author

Regulation of sphingomyelin phosphodiesterase acid-like 3A gene (SMPDL3A) by liver X receptors.

Molecular pharmacology·2012
Same author

Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarring.

Bioorganic & medicinal chemistry letters·2012

Liver X receptors (LXRs) are promising drug targets for various diseases. However, challenges like hypertriglyceridemia and species-specific gene regulation must be addressed for effective LXR-based therapeutics.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Liver X receptors (LXRs) are nuclear receptors implicated in various physiological processes.
  • LXRs represent potential therapeutic targets for a range of diseases.

Purpose of the Study:

  • To discuss the therapeutic potential of LXRs.
  • To highlight the challenges and strategies for developing LXR-based drugs.

Main Methods:

  • Review of existing literature on LXR function and pharmacology.
  • Analysis of LXR-mediated gene regulation and associated adverse effects.

Main Results:

  • LXR activation offers therapeutic opportunities but is associated with hypertriglyceridemia.
  • Species-dependent differences in LXR gene regulation present a hurdle for drug development.

Related Experiment Videos

Conclusions:

  • Overcoming challenges in LXR drug development requires both classical and molecular strategies.
  • Further research into LXR mechanisms is crucial for advancing LXR-based therapeutics.